MODERATOR
:
SPEAKER
(S):
JoAnn Moulds, PhD, MT(ASCP)SBB, Director, Scientific Support Services, LifeShare Blood Centers
Considerations for Donor Center DNA Testing
Marion E. Reid, PhD, Director, Immunohematology and Immunochemistry Laboratories, New York Blood Center
Interplay of DNA-Based Asays and Hemagglutintation
Description
Serologic antigen typing has limitations, both in availability of reagents, as well as specificity. Technology for performing molecular typing is now available to laboratories for routine testing. The speakers will discuss the application for both donors and patients. Topics will include the development of AABB standards in this area, quality control and considerations for routine use of these techniques, and where the biggest benefits may be seen in replacing serologic methods for typing.
LEARNER OUTCOMES:
-
Define the benefits in patient/ diagnostic testing for the use of molecular methods.
-
Describe the issues of consent for donors and for patients related to molecular typing for antigens and hemoglobin S trait.
-
Identify the standards and quality control relevant to molecular techniques.
-
List the benefits of molecular typing for large-scale donor screening.
-
Outline the reimbursement strategies for services related to molecular typing.
| CE Category | CE Value |
|---|
|
California Clinical Laboratory Personnel |
1.5 |
|
California Nurse |
1.8 |
|
Florida Laboratory Personnel |
1.8 |
|
General Attendee |
1.5 |
|
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.